-
-
(Avoiding Cardiovascular Events through Combination Therapy
in Patients Living with Systolic Hypertension) In this study, we aim
to show that Lotrel (combination of amlodipine and benazepril)
is superior to the combination of benazepril and HCTZ (hydrochlorthiazide)
in high-risk hypertensive patients in delaying fatal and non-fatal
cardiovascular (heart related) events.
- Actos in Metabolic Syndrome
-
In this trial we will investigate how a medicine called Actos (pioglitazone)
affects blood pressure and the way arteries in the bodywork in patients with
metabolic syndrome.
- MRI versus Ultrasound Evaluation of Endothelial Function
-
We will compare the results of BART and MRI studies to help us determine if MRI is a practical way to evaluate endothelial function
-
-
A Multicenter, Randomized, Double-Blind Placebo Controlled Study
of the Effect of Ezetimibe plus Simvastatin Compared to Simvastatin
Alone on Flow Mediated Brachial Artery Vasoactivity in Subjects
with Primary Hypercholesterolemia.
-
-
In this study, we aim to show that Micardis HCT (telmisartan
80 mg/ hydrochlorothizide 25 mg) is superior to placebo (the sugar
pill or the pill with no active drug) in lowering blood pressure
and is at least as effective as Diovan HCT (valsartan 160 mg/ hydrochlorothizide
25 mg) in lowering blood pressure.